# Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients

> **NCT01017796** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of Thessaly** · enrollment: 100 (estimated)

## Conditions studied

- Contrast Induced Nephropathy

## Interventions

- **DRUG:** N-acetylcysteine and ascorbic acid

## Key facts

- **NCT ID:** NCT01017796
- **Lead sponsor:** University of Thessaly
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2010-01
- **Final completion:** 2010-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017796, "Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01017796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*